Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

R. Harrup · SciRah

Researcher profile · Semantic Scholar

R. Harrup

Share profile

R. Harrup — researcher profile on SciRah

h-index: 19
Works: 120
Citations: 1,272

Most-cited papers

Phase 1 study of selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL.
C. Tam, J. Trotman, Stephen Samuel Opat, J. Burger +17 more
2019Blood321 citations Open access
Semantic Scholar
The MURANO study: final analysis and retreatment/crossover substudy results of VenR for patients with relapsed/refractory CLL
A. Kater, R. Harrup, T. Kipps, B. Eichhorst +18 more
2025Blood59 citations Open access
Semantic Scholar
Roxadustat for the treatment of anemia in patients with lower‐risk myelodysplastic syndrome: Open‐label, dose‐selection, lead‐in stage of a phase 3 study
D. Henry, J. Glaspy, R. Harrup, M. Mittelman +8 more
2021American journal of hematology/oncology58 citations Open access
Semantic Scholar
Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen
Meghan C. Thompson, R. Harrup, Catherine C. Coombs, L. Roeker +34 more
2022Blood Advances53 citations Open access
Semantic Scholar
Factors influencing the provision of fertility counseling and impact on quality of life in adolescents and young adults with cancer
G. Skaczkowski, V. White, K. Thompson, H. Bibby +7 more
2018Journal of psychosocial oncology45 citations Open access
Semantic Scholar
The incidence and natural history of dasatinib complications in the treatment of chronic myeloid leukemia.
L. Fox, K. Cummins, B. Costello, D. Yeung +17 more
2017Blood Advances41 citations Open access
Semantic Scholar
Inconsistencies and time delays in site‐specific research approvals hinder collaborative clinical research in Australia
Victoria White, Helen Bibby, M. Green, A. Anazodo +9 more
2016Internal medicine journal (Print)31 citations Open access
Semantic Scholar
Do Australian adolescents' and young adults' experiences of cancer care influence their quality of life?
G. Skaczkowski, V. White, K. Thompson, H. Bibby +8 more
2018Psycho-Oncology27 citations Open access
Semantic Scholar
Asciminib Monotherapy as Frontline Treatment of Chronic-Phase Chronic Myeloid Leukemia: Results from the ASCEND Study.
David T. Yeung, N. Shanmuganathan, John Reynolds, S. Branford +17 more
2024Blood26 citations
Semantic Scholar
Medical Oncology Group of Australia position statement and membership survey on voluntary assisted dying
C. Karapetis, Brian Stein, B. Koczwara, R. Harrup +6 more
2018Internal medicine journal (Print)26 citations Open access
Semantic Scholar
Experiences of Care of Adolescents and Young Adults with Cancer in Australia
V. White, G. Skaczkowski, K. Thompson, H. Bibby +9 more
2018Journal of Adolescent and Young Adult Oncology26 citations Open access
Semantic Scholar
The natural history of vascular and other complications in patients treated with nilotinib for chronic myeloid leukemia.
A. Minson, K. Cummins, L. Fox, B. Costello +18 more
2019Blood Advances24 citations Open access
Semantic Scholar
Nivolumab and Ipilimumab Combination Treatment in Advanced Ovarian and Endometrial Clear Cell Cancers: A Nonrandomized Clinical Trial.
Bo Gao, M. Carlino, M. Michael, C. Underhill +18 more
2025JAMA Oncology23 citations Open access
Semantic Scholar
Clinical management of Australian adolescents and young adults with acute lymphoblastic and myeloid leukemias: A national population‐based study
V. White, G. Skaczkowski, R. Pinkerton, M. Coory +10 more
2018Pediatric Blood & Cancer23 citations Open access
Semantic Scholar
Factors influencing the documentation of fertility-related discussions for adolescents and young adults with cancer.
G. Skaczkowski, V. White, K. Thompson, H. Bibby +9 more
2018European Journal of Oncology Nursing21 citations Open access
Semantic Scholar
Efficacy of Subsequent Novel Targeted Therapies, Including Repeated Venetoclax-Rituximab (VenR), in Patients (Pts) with Relapsed/Refractory Chronic Lymphocytic Leukemia (R/R CLL) Previously Treated with Fixed-Duration Venr in the Murano Study
R. Harrup, C. Owen, J. D'Rozario, T. Robak +9 more
202019 citations Open access
Semantic Scholar
Roxadustat (FG4592; ASP1517; AZD9941) in the Treatment of Anemia in Patients with Lower Risk Myelodysplastic Syndrome (LR-MDS) and Low Red Blood Cell (RBC) Transfusion Burden (LTB)
D. Henry, J. Glaspy, R. Harrup, M. Mittelman +6 more
2019Blood18 citations Open access
Semantic Scholar
Roxadustat versus placebo for patients with lower‐risk myelodysplastic syndrome: MATTERHORN phase 3, double‐blind, randomized controlled trial
Moshe Mittelman, D. Henry, John A. Glaspy, A. Tombak +6 more
2024American journal of hematology/oncology16 citations Open access
Semantic Scholar
A Qualitative Study of Medical Oncologists’ Experiences of Their Profession and Workforce Sustainability
A. Broom, W. K. Tim Wong, E. Kirby, D. Sibbritt +3 more
2016PLoS ONE16 citations Open access
Semantic Scholar
MURANO: Final 7 year follow up and retreatment analysis in venetoclax‐rituximab (VenR)‐treated patients with relapsed/refractory chronic lymphocytic leukemia (R/R CLL)
A. Kater, R. Harrup, T. Kipps, B. Eichhorst +16 more
2023Hematological Oncology15 citations Open access
Semantic Scholar
Australian genome-wide association study confirms higher female risk for adult glioma associated with variants in the region of CCDC26
K. Alpen, C. Vajdic, R. MacInnis, R. Milne +17 more
2022Neuro-Oncology13 citations Open access
Semantic Scholar
Chronic lymphocytic leukaemia Australasian consensus practice statement
M. Anderson, R. Bennett, X. Badoux, Giles Best +21 more
2023Internal medicine journal (Print)12 citations Open access
Semantic Scholar
The Australian Medical Oncologist Workforce Survey: The profile and challenges of medical oncology.
Zarnie Lwin, A. Broom, D. Sibbritt, Kay Francis +3 more
2018Seminars in Oncology12 citations Open access
Semantic Scholar
713MO Nivolumab and ipilimumab combination treatment in advanced gynaecological clear cell cancers: Results from the phase II MoST-CIRCUIT trial
O. Klein, M. Carlino, M. Michael, C. Underhill +12 more
2024Annals of Oncology11 citations
Semantic Scholar
S201: FINAL 7-YEAR FOLLOW UP AND RETREATMENT SUBSTUDY ANALYSIS OF MURANO: VENETOCLAX-RITUXIMAB (VENR)-TREATED PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (R/R CLL)
A. Kater, R. Harrup, T. Kipps, B. Eichhorst +16 more
2023HemaSphere11 citations Open access
Semantic Scholar
Management of Sarcoma in Adolescents and Young Adults: An Australian Population-Based Study
V. White, L. Orme, G. Skaczkowski, R. Pinkerton +10 more
2019Journal of Adolescent and Young Adult Oncology11 citations Open access
Semantic Scholar
Genomic Therapy Matching in Rare and Refractory Cancers
F. P. Lin, S. Thavaneswaran, John P. Grady, C. Napier +30 more
2026JAMA Oncology9 citations Open access
Semantic Scholar
A signal-seeking phase 2 study of Trastuzumab emtansine in tumours harbouring HER2 amplification or mutation
S. Thavaneswaran, F. Lin, J. Grady, D. Espinoza +17 more
2024npj Precision Oncology8 citations Open access
Semantic Scholar
Beyond standard data collection – the promise and potential of BRAIN (Brain tumour Registry Australia INnovation and translation registry)
Lucy Gately, K. Drummond, M. Rosenthal, R. Harrup +11 more
2022BMC Cancer8 citations Open access
Semantic Scholar
Clinical trial participation by adolescents and young adults with cancer: A continued cause for concern?
V. White, G. Skaczkowski, A. Anazodo, H. Bibby +10 more
2018Seminars in Oncology8 citations Open access
Semantic Scholar
Acute myeloid leukemia with diabetes insipidus and hypophyseal infiltration
R. Harrup, My Pham, Gerald McInerney
2016Asia-Pacific Journal of Clinical Oncology8 citations
Semantic Scholar
Nivolumab and ipilimumab combination treatment in advanced dMMR/MSI-H non-colorectal cancers: Results from a phase II trial
M. Carlino, Bo Gao, M. Michael, Henry Marshall +21 more
2025JAMA Oncology7 citations
Semantic Scholar
ALLG APML5: bioavailability and safety of oral arsenic trioxide assessed during consolidation therapy for APL
H. Iland, John Reynolds, Alan Boddy, H. B. Schultz +17 more
2025Blood Advances7 citations Open access
Semantic Scholar
Update of the Ascend-CML Study of Frontline Asciminib: High Rate of Optimal Response and Resistance Due to Mutations Is Rare
David T. Yeung, N. Shanmuganathan, Agnes S. M. Yong, J. Shortt +17 more
2024Blood7 citations
Semantic Scholar
Outpatient autologous stem cell transplantation in Royal Hobart Hospital, Tasmania: a single‐centre, retrospective review in the Australian setting
Xuan Tan, Chang-Yang Yew, S. Ragg, R. Harrup +1 more
2021Internal medicine journal (Print)7 citations
Semantic Scholar
Exploring the impact and experience of fractional work in medicine: a qualitative study of medical oncologists in Australia
E. Kirby, A. Broom, D. Karikios, R. Harrup +1 more
2019BMJ Open7 citations Open access
Semantic Scholar
Combination of Nilotinib and Pegylated Interferon Alfa-2b Results in High Molecular Response Rates in Chronic Phase CML: Interim Results of the ALLG CML 11 Pinnacle Study
D. Yeung, A. Grigg, N. Shanmuganathan, I. Cunningham +18 more
2018Blood7 citations Open access
Semantic Scholar
A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma
L. Gately, C. Mesía, J. Sepúlveda, S. del Barco +34 more
2023Journal of Neuro-Oncology6 citations Open access
Semantic Scholar
Clinical Trials in the Brain Tumour Population: Challenges and Strategies for the Future
Hui K. Gan, B. Day, R. Harrup, T. Johns +4 more
2023Current Oncology Reports5 citations
Semantic Scholar
Excellent Early and Major Molecular Responses Observed with Asciminib Treatment for CP-CML: Results from the ALLG CML13 Ascend-CML Study
David T. Yeung, N. Shanmuganathan, J. Reynolds, S. Branford +19 more
2023Blood5 citations Open access
Semantic Scholar
Treatment and Outcomes for Central Nervous System Tumors in Australian Adolescents and Young Adults: A Population-Based National Study
R. Harrup, V. White, M. Coory, R. Walker +10 more
2020Journal of Adolescent and Young Adult Oncology5 citations Open access
Semantic Scholar
CRISTALLO: Results from a Phase III Trial of Venetoclax-Obinutuzumab Versus Fludarabine, Cyclophosphamide and Rituximab or Bendamustine-Rituximab in Patients with Untreated Chronic Lymphocytic Leukemia without Del(17p) or TP53 Mutations
Jeff P. Sharman, L. Laurenti, E. Ferrant, Luis Felipe Casado Montero +12 more
2024Blood4 citations Open access
Semantic Scholar
Multi-Arm GlioblastoMa Australasia (MAGMA): protocol for a multiarm randomised clinical trial for people affected by glioblastoma
B. Kong, H. Sim, E. Barnes, A. Nowak +15 more
2022BMJ Open4 citations Open access
Semantic Scholar
Early and Deep Molecular Responses Achieved with Frontline Asciminib in Chronic Phase CML - Interim Results from ALLG CML13 Ascend-CML
D. Yeung, N. Shanmuganathan, J. Reynolds, S. Branford +17 more
2022Blood4 citations Open access
Semantic Scholar
Oral Roxadustat Demonstrates Efficacy in Anemia Secondary to Lower-Risk Myelodysplastic Syndrome Irrespective of Ring Sideroblasts and Baseline Erythropoietin Levels
D. Henry, J. Glaspy, R. Harrup, M. Mittelman +7 more
20204 citations Open access
Semantic Scholar
Combination of Nilotinib and Pegylated Interferon Alfa-2B Results in High Rates of MR4.5 at 24 Months - Primary Analysis of the ALLG CML 11 Pinnacle Study
D. Yeung, N. Shanmuganathan, A. Grigg, I. Cunningham +17 more
2019Blood4 citations Open access
Semantic Scholar
Primary analysis of the phase 3 randomized trial of selinexor and lenalidomide versus lenalidomide alone as maintenance therapy post autologous stem cell transplant for patients with newly diagnosed multiple myeloma (ALLG MM23; SEALAND)
M. Rees, M. Lasica, A. Kalff, Michael Low +19 more
2025Blood3 citations
Semantic Scholar
282P Nivolumab and ipilimumab combination treatment in advanced intrahepatic cholangiocarcinoma and gallbladder cancer
O. Klein, M. Carlino, M. Brown, S. Harris +16 more
2024Annals of Oncology3 citations
Semantic Scholar
Patient and carer experiences of living with multiple myeloma and myelodysplastic syndrome
J. Roydhouse, D. Thompson, Louise Nicholson, R. Harrup +2 more
2023Psycho-Oncology3 citations
Semantic Scholar
Efficacy and Safety of Roxadustat for Treatment of Anemia in Patients with Lower-Risk Myelodysplastic Syndrome (LR-MDS) with Low Red Blood Cell (RBC) Transfusion Burden: Results of Phase III Matterhorn Study
Moshe Mittelman, D. Henry, John A. Glaspy, A. Tombak +6 more
2023Blood3 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Conyers×9
Invite
R. Conyers — researcher profile on SciRah
M. Phillips×9
Invite
M. Phillips — researcher profile on SciRah
A. Anazodo×9
Invite
A. Anazodo — researcher profile on SciRah
G. Skaczkowski×8
Invite
G. Skaczkowski — researcher profile on SciRah

×8

Invite

V. White — researcher profile on SciRah

Invite

K. Thompson — researcher profile on SciRah

Invite

H. Bibby — researcher profile on SciRah

Invite

M. Coory — researcher profile on SciRah

Invite

L. Orme — researcher profile on SciRah

Invite

M. Osborn — researcher profile on SciRah

R. Pinkerton×7

Invite

R. Pinkerton — researcher profile on SciRah

Invite

M. Lefebure — researcher profile on SciRah